A TiVCrMoC3 MXene-Based Sustained-Release Vancomycin Nanoplatform Mitigates Septic Arthritis through Modulation of Bacterial Acetate Metabolism.
- DOI
- 10.1021/acsami.6c14214
- Published
- 2026 Nov 2
- Container
- ACS applied materials & interfaces
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1021/acsami.6c14214,
title = {A TiVCrMoC3 MXene-Based Sustained-Release Vancomycin Nanoplatform Mitigates Septic Arthritis through Modulation of Bacterial Acetate Metabolism.},
author = {Yu X and Yan X and Bai C and Ma C and He Q and Chu Z and Liu S and Fang G and Zhang H and Liang W},
year = {2026},
journal = {ACS applied materials \& interfaces},
doi = {10.1021/acsami.6c14214},
url = {https://doi.org/10.1021/acsami.6c14214}
}RIS
TY - JOUR TI - A TiVCrMoC3 MXene-Based Sustained-Release Vancomycin Nanoplatform Mitigates Septic Arthritis through Modulation of Bacterial Acetate Metabolism. AU - Yu X AU - Yan X AU - Bai C AU - Ma C AU - He Q AU - Chu Z AU - Liu S AU - Fang G AU - Zhang H AU - Liang W PY - 2026 JO - ACS applied materials & interfaces DO - 10.1021/acsami.6c14214 UR - https://doi.org/10.1021/acsami.6c14214 ER -
APA
X, Y., X, Y., C, B., C, M., Q, H., Z, C., S, L., G, F., H, Z., & W, L. (2026). A TiVCrMoC3 MXene-Based Sustained-Release Vancomycin Nanoplatform Mitigates Septic Arthritis through Modulation of Bacterial Acetate Metabolism.. ACS applied materials & interfaces. https://doi.org/10.1021/acsami.6c14214
Source records
- pubmed · retrieved 2026-11-10T11:07:34.782Z